BioNTech plots first wave of cancer launches in 2026 as COVID vaccine sales continue to disappoint

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the next leg of its commercial journey. | With plans to have at least 10 ... Read More

BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales

The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05. Read More

GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK ... Read More

Pfizer jumps as investors look past Covid vaccine forecast to possible price hikes

Vaccine rival Moderna (MRNA) also said its sees "improved visibility" in its Covid sales ... our business in future periods, helping us to further invest in activities that drive Pfizer ... Read More

After COVID excess, Pfizer bracing for a hangover in 2023

Pfizer reaped the rewards of its COVID-19 vaccines ... in pandemic sales has also returned investors' attention to Pfizer's ability to generate growth in other areas of its business, as big ... Read More

Pfizer hikes COVID vaccine sales forecast for 2021 to $33.5bn

Continuing orders for Pfizer's BioNTech-partnered ... Even without the windfall, underlying sales grew 10%, driven in particular by gains for pneumococcal vaccine Prevnar 13 and Vyndaqel/Vyndamax ... Read More

Moderna’s COVID vaccine sales plunge, as analysts debate future of once-hot company

Sales of Spikevax, the Cambridge company’s only marketed product, plummeted to $167 million from $1.9 billion, the firm reported on Thursday. That actually beat analysts’ predictions of $97.5 million. Read More

Vaccine sales plunge for Sanofi in fourth quarter

In the fourth quarter, polio/pertussis/hib (PPH) vaccines sales decreased 16.9% to €443 million, reflecting lower sales in the rest of the world. In addition, PENTAXIM sales in China decreased ... Read More

pfizer inc.

Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Pfizer CEO Albert Bourla criticized the ... Read More

Pfizer Blasts Earnings Forecast, Sees $33.5 Billion in COVID Vaccine Sales

Pfizer Inc. (PFE) posted stronger-than-expected second quarter earnings Wednesday, while boosting its 2021 profit guidance, as the drugmaker said its coronavirus vaccine sales would reach at ... Read More

BioNTech Swings to Net Loss on Lower Covid Vaccine Sales

By Helena Smolak BioNTech swung to a net loss in the first quarter on plummeted revenue after a sharp decline in its Covid-19 vaccine sales. The ... Read More

China Vehicle Sales Rebound

China vehicle sales rose in March, bouncing back from a weaker showing the prior month and registering a gradual pace of growth for the first quarter of the year, signaling that demand may be ... Read More